Matthew Vincent Dolan - 06 Mar 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
SVP Corporate Strategy-Develop
Signature
By: Jereme Sylvain For: Matthew V Dolan
Issuer symbol
DXCM
Transactions as of
06 Mar 2023
Net transactions value
-$25,854
Form type
4
Filing time
06 Mar 2023, 19:04:20 UTC
Previous filing
06 Sep 2022
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale $25,854 -226 -0.84% $114.40 26,536 06 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan which was amended on December 6, 2022. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 26,536 unvested restricted stock units, 11,556 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,192 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,788 of which were granted on March 8, 2020 and shall vest through March 8, 2023.